Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obalon
MedTech
Allurion bumps up series C to $27M as it revs up for U.S. trial
Allurion Technologies has raised $27 million in series C funding for its swallowable, procedureless, weight-loss balloon.
Amirah Al Idrus
Jul 11, 2017 9:30am
Obalon launches $75M IPO for ingestible weight loss balloon
Oct 6, 2016 4:25pm
Obalon aims for $75M IPO to back swallowable obesity device launch
Sep 9, 2016 10:58am